These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 12168945

  • 21. Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial.
    Palmeri S, Leonardi V, Gebbia V, De Bella MT, Ferraù F, Faillú G, Spatafora M, Valenza R, Di Vita G, Vitello S, Carroccio R, Sciortino G, Vaglica M, Accurso V, Agostara B, Licata G.
    Lung Cancer; 2001 Oct; 34(1):115-23. PubMed ID: 11557121
    [Abstract] [Full Text] [Related]

  • 22. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
    Argiris A, Liptay M, LaCombe M, Marymont M, Kies MS, Sundaresan S, Masters G.
    Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Biweekly triplet chemotherapy with gemcitabine, cisplatin and vinorelbine for advanced chemotherapy naïve non-small cell lung cancer.
    Keskin S, Tas F, Ekenel M, Kilic L, Sen F, Yildiz I, Karabulut S, Ciftci R, Vatansever S.
    Tumori; 2013 Aug; 99(4):463-8. PubMed ID: 24326833
    [Abstract] [Full Text] [Related]

  • 28. Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer.
    Lorusso V, Carpagnano F, Frasci G, Panza N, Di Rienzo G, Cisternino ML, Napoli G, Orlando S, Cinieri S, Brunetti C, Palazzo S, De Lena M.
    J Clin Oncol; 2000 Jan; 18(2):405-11. PubMed ID: 10637256
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II study.
    Feliu J, Martin G, Lizón J, Chacón JI, Dorta J, de Castro J, Rodríguez A, Sánchez Heras B, Torrego JC, Espinosa E, González Barón M, Oncopaz Cooperative Group, Spain.
    Ann Oncol; 2001 Oct; 12(10):1369-74. PubMed ID: 11762806
    [Abstract] [Full Text] [Related]

  • 31. Randomized phase II study of carboplatin-paclitaxel or gemcitabine-vinorelbine in patients with advanced nonsmall cell lung cancer and a performance status of 2: West Japan Thoracic Oncology Group 0004.
    Saito H, Nakagawa K, Takeda K, Iwamoto Y, Ando M, Maeda M, Katakami N, Nakano T, Kurata T, Fukuoka M.
    Am J Clin Oncol; 2012 Feb; 35(1):58-63. PubMed ID: 21293243
    [Abstract] [Full Text] [Related]

  • 32. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.
    Lee DH, Han JY, Cho KH, Pyo HR, Kim HY, Yoon SJ, Lee JS.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1037-44. PubMed ID: 16024178
    [Abstract] [Full Text] [Related]

  • 33. Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.
    Hainsworth JD, Burris HA, Billings FT, Bradof JE, Baker M, Greco FA.
    Cancer; 2001 Nov 01; 92(9):2391-8. PubMed ID: 11745295
    [Abstract] [Full Text] [Related]

  • 34. Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104.
    Yamamoto N, Nakagawa K, Uejima H, Sugiura T, Takada Y, Negoro S, Matsui K, Kashii T, Takada M, Nakanishi Y, Kato T, Fukuoka M, West Japan Thoracic Oncology Group (WJTOG).
    Cancer; 2006 Aug 01; 107(3):599-605. PubMed ID: 16804877
    [Abstract] [Full Text] [Related]

  • 35. Gemcitabine, vinorelbine, and Cisplatin in the treatment of advanced nonsmall cell lung cancer.
    Hasturk S, Hatabay N, Ece F, Karatasli M, Hanta I.
    Am J Clin Oncol; 2009 Jun 01; 32(3):280-5. PubMed ID: 19433960
    [Abstract] [Full Text] [Related]

  • 36. Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).
    Kosmidis PA, Fountzilas G, Eleftheraki AG, Kalofonos HP, Pentheroudakis G, Skarlos D, Dimopoulos MA, Bafaloukos D, Pectasides D, Samantas E, Boukovinas J, Lambaki S, Katirtzoglou N, Bakogiannis C, Syrigos KN.
    Ann Oncol; 2011 Apr 01; 22(4):827-834. PubMed ID: 20880999
    [Abstract] [Full Text] [Related]

  • 37. Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).
    Boni C, Tiseo M, Boni L, Baldini E, Recchia F, Barone C, Grossi F, Germano D, Matano E, Marini G, Labianca R, Di Costanzo F, Bagnulo A, Pennucci C, Caroti C, Mencoboni M, Zanelli F, Prochilo T, Cafferata MA, Ardizzoni A, Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC).
    Br J Cancer; 2012 Feb 14; 106(4):658-65. PubMed ID: 22240782
    [Abstract] [Full Text] [Related]

  • 38. Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial.
    Gridelli C, Cigolari S, Gallo C, Manzione L, Ianniello GP, Frontini L, Ferraù F, Robbiati SF, Adamo V, Gasparini G, Novello S, Perrone F, MILES Investigators.
    Lung Cancer; 2001 Feb 14; 31(2-3):277-84. PubMed ID: 11165408
    [Abstract] [Full Text] [Related]

  • 39. Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma.
    Vallejo C, Romero A, Perez J, Cuevas M, Lacava J, Sabatini C, Dominguez M, Rodriguez R, Barbieri M, Romero Acuña L, Romero Acuña J, Langhi M, Amato S, Salvadori M, Ortiz E, Machiavelli M, Leone B.
    Am J Clin Oncol; 1996 Dec 14; 19(6):584-8. PubMed ID: 8931677
    [Abstract] [Full Text] [Related]

  • 40. Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study.
    Kubota K, Kawahara M, Ogawara M, Nishiwaki Y, Komuta K, Minato K, Fujita Y, Teramukai S, Fukushima M, Furuse K, Japan Multi-National Trial Organisation.
    Lancet Oncol; 2008 Dec 14; 9(12):1135-42. PubMed ID: 19013107
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.